AKT1 and Hyperglycemia: At the molecular level, T2DM is manifested by the activation of serine kinase cascades due to hyperglycemia and ROS that dysregulate the insulin signaling mechanism in the phosphatidylinositol 3-kinase/AKT (P13K/AKT) pathway, which is implicated in insulin secretion and glucose transfer.